Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis

by jlohrconsulting | Sep 26, 2025 | Uncategorized

J Clin Psychiatry. 2025 Sep 22;86(4):25m15863. doi: 10.4088/JCP.25m15863. ABSTRACT Objective: In treatment-resistant depression (TRD), augmentation with aripiprazole (A-ARI) or combination therapy by adding bupropion (C-BUP) has been reported as more effective than...

Failing Public Health Again? Analytical Review of Depression and Suicidality From Finasteride

by jlohrconsulting | Sep 26, 2025 | Uncategorized

J Clin Psychiatry. 2025 Sep 22;86(4):25nr15862. doi: 10.4088/JCP.25nr15862. ABSTRACT Background: Finasteride, widely prescribed for androgenetic alopecia, has long been suspected of causing severe neuropsychiatric reactions, including depression, anxiety, and...

Comparative Effects of Repeated Ketamine Infusion Versus Intranasal Esketamine in Patients With Treatment-Resistant Depression: A Retrospective Chart Review

by jlohrconsulting | Sep 26, 2025 | Uncategorized

J Clin Psychiatry. 2025 Sep 22;86(4):25m15789. doi: 10.4088/JCP.25m15789. ABSTRACT Objective: Both intravenous (IV) racemic ketamine and intranasal (IN) esketamine have emerged as rapid-acting antidepressants for treatment-resistant depression (TRD) and are...

Global prevalence of post-miscarriage anxiety, depression, and stress: a systematic review and meta-analysis

by jlohrconsulting | Sep 26, 2025 | Uncategorized

J Glob Health. 2025 Sep 26;15:04245. doi: 10.7189/jogh.15.04245. ABSTRACT BACKGROUND: Mental disorders, ranked as the sixth leading cause of disability-adjusted life years in 2017, present significant challenges to healthcare systems. Anxiety and depression are...

Investigating the Role of Place of Residence in the Relationship between Discrimination and Mental Health in American Indian Adults

by jlohrconsulting | Sep 26, 2025 | Uncategorized

Am Indian Alsk Native Ment Health Res. 2025;32(3):1-17. doi: 10.5820/aian.3203.2025.1. ABSTRACT Experiences of discrimination are linked to mental health in American Indians. Less is known about how place of residence (i.e., living on or off a reservation) relates to...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments